Pembrolizumab in people with HIV-associated progressive multifocal leukoencephalopathy: a retrospective case series.
Infection·
- DOI
- 10.1007/s15010-026-02939-z
- PMID
- 42640409
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- Publisher unavailable
- Article type
- journal-article
- Integrity
- current
Why this research matters now
HIV-associated PML carries high mortality and lacks a specific antiviral therapy, so identifying candidate salvage treatments is relevant to clinical management of this serious complication.
Structured evidence summary
Research question
The article examines whether pembrolizumab could be used as a treatment option for people with HIV-associated progressive multifocal leukoencephalopathy, a condition lacking a specific antiviral therapy.
Study design
A retrospective single-centre case series reporting on six patients who received pembrolizumab.
Population and setting
Six people with HIV who had progressive multifocal leukoencephalopathy and were treated at a single centre.
Main findings
Of the six patients treated with pembrolizumab, four experienced clinical improvement or stabilisation. The authors suggest pembrolizumab as a potential salvage option in this population.
Public-health relevance
HIV-associated PML carries high mortality and lacks a specific antiviral therapy, so identifying candidate salvage treatments is relevant to clinical management of this serious complication.
Important limitations
The summary is limited to the supplied single-article abstract and metadata, which describe only six patients without a control group, and decision-grade interpretation would require review of the original paper including its own stated limitations.
GIDS interpretation
The paper addresses a treatment question in HIV-associated PML and may aid discoverability of candidate salvage therapies in the GIDS evidence base; no connection to a live surveillance signal is established from the supplied information.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.